Abbott "fully confident" in exec with missing creds | Personnel Moves
Abbott continues to defend long-time executive and new pharmaceutical spin-out chief Richard Gonzalez amid a resume controversy.

[1] Abbott CEO "fully confident" in future pharma spin-out chief, despite resume fuss [2]
Abbott [3] (NYSE:ABT [4]) chairman & CEO Miles White said he's "fully confident" in Richard Gonzalez as the new head of the company's AbbVie pharmaceutical spin-out, in spite of the ongoing kerfuffle over Gonzalez's "misstated" college credentials.
The healthcare giant confirmed [5] last week that regulatory filings and company documents had mistakenly attributed to Gonzalez bachelor's and master's degrees, when the long-time Abbott executive never finished college.